AF contributes to increased stroke risk via various mechanisms, including deranged blood
constituents, vessel wall abnormalities and abnormal blood flow. This excess risk is …

Background Long-term oral anticoagulation is the mainstay therapy for thromboembolic (TE)
prevention in patients with atrial fibrillation. However, left atrial appendage occlusion (LAAO) …

In the past, the most common type of atrial fibrillation leading to stroke was valvular; this was
predominantly due to the prevalence of rheumatic fever, but with the advent of better …

Atrial fibrillation (AF) is the most common clinically relevant arrhythmia and confers a fivefold
increased risk for stroke. Cardioembolic stroke secondary to AF is a devastating event, but is …

Background: Complete real-world data on the indications and outcomes of left atrial
appendage closure (LAAC) outside of clinical trials are rare. In this study, we stratified …

Introduction: Atrial fibrillation (AF) poses a significant risk of stroke. Left atrial appendage
occlusion (LAAO) is an alternative for patients with contraindications to oral anticoagulation …

Referring patients with nonvalvular atrial fibrillation (NVAF) for left atrial appendage closure
(LAAC) device should be based on bleeding risks, poor anticoagulation compliance, and …

Background and Objective. Thrombolytics and anticoagulants are conventional drugs for
ischemic stroke (IS) treatment, whereas some patients have unfavorable responses to these …

Atrial fibrillation (AF) is one of the most common sustained dysrhythmias that increases in
prevalence with age, and is associated with strokes that can lead to significant patient …

Background Antithrombotic management in patients with atrial fibrillation (AF) that have
undergone heart valve surgery may be challenging, especially in the context of …